Compared to patients with elevated ProGRP levels, those with normal levels showed a trend toward longer median PFS, but the difference was not statistically significant (P=0.62).
← all excerpts
Real-world evidence on the efficacy, safety, and biomarkers of immunotherapy combined with radiotherapy in limited-stage small cell lung cancer.
1
—
—